Prof Sharon Peacock Cambridge Uni, her work sequencing variants may be required for at least 10 yrs
https://www.bbc.co.uk/news/uk-56019995
#Novacyt #ALNOV #NCYT
https://www.bbc.co.uk/news/uk-56019995
#Novacyt #ALNOV #NCYT
Prof Sharon Peacock will be speaking at Novacyt's NovaTalk on 26th Feb
https://twitter.com/gggg2120/status/1359583252080701456?s=19
#Novacyt #ALNOV #NCYT
https://twitter.com/PrimerdesignLtd/status/1357658991103516674?s=19
https://twitter.com/gggg2120/status/1359583252080701456?s=19
#Novacyt #ALNOV #NCYT
https://twitter.com/PrimerdesignLtd/status/1357658991103516674?s=19
(April) Novacyt Partners With AstraZeneca, GSK, University Of Cambridge To Increase COVID-19 Testing
#Novacyt #ALNOV #NCYT
#Novacyt #ALNOV #NCYT
"5-10% of positive tests are selected randomly to be sent on for further genome analysis but the consortium says that it has an aim to genetically screen every positive coronavirus test"
Covid-19 Genomics UK Consortium
#Novacyt #ALNOV #NCYT
Covid-19 Genomics UK Consortium
#Novacyt #ALNOV #NCYT
“primary challenge for COVID-19 diagnostics companies is ensuring their products continue to accurately test for the virus, regardless of the variant, and to innovate at the challenging pace required to remain clinically relevant,” Graham Mullis, Novacyt https://www.bioworld.com/articles/503479-covid-19-test-makers-are-adapting-for-variants